Open main menu

HemOnc.org - A Hematology Oncology Wiki β

Changes

Avatrombopag (Doptelet)

108 bytes removed, 15:24, 29 October 2017
m
no edit summary
==Preliminary data==
===[[Autoimmune thrombocytopenic purpura (ITP)]]===
<span
style="background:#00CD00;
padding:3px 6px 3px 6px;
border-color:black;
border-width:2px;
border-style:solid;">Randomized Phase II, >20 per arm</span>
# Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. [http://bloodjournal.hematologylibrary.org/content/123/25/3887.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/24802775 PubMed]
==Also known as==
*'''Code names:''' YM477, AKR 501
[[Category:Drug index]]
[[Category:Oral medications]]
 
[[Category:Hematopoietic growth factors]]
[[Category:Megakaryocyte growth factors]]
LookupUsers, editors, emailconfirmed
23,817
edits